<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The objective of this study is to determine the causes and predictors of <z:hpo ids='HP_0011420'>death</z:hpo> in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) patients </plain></SENT>
<SENT sid="1" pm="."><plain>Causes of <z:hpo ids='HP_0011420'>death</z:hpo> were defined based on <z:hpo ids='HP_0011420'>death</z:hpo> certificates, medical records, and information collected from doctors and relatives </plain></SENT>
<SENT sid="2" pm="."><plain>Possible variables predicting mortality were assessed by Kaplan-Meier and Cox regression methods </plain></SENT>
<SENT sid="3" pm="."><plain>The multivariate model was validated using the bootstrap method, and the hazard ratios were adjusted according to the shrinkage coefficient </plain></SENT>
<SENT sid="4" pm="."><plain>One hundred eighty-one patients were included, and two patients were lost to follow-up </plain></SENT>
<SENT sid="5" pm="."><plain>The median (IR) age at T (0) and disease duration of the 179 patients were 26.7 (21.8-34.6) and 8.2 (4.3-12.4) years, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>After a median (IR) follow-up of 3.3 (3.1-3.5) years, 13 (7.3 %) patients died due to end-organ failure (5), <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> (5), disease activity (1), and <z:e sem="disease" ids="C0003972" disease_type="Disease or Syndrome" abbrv="ascvd">atherosclerotic cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) (1) </plain></SENT>
<SENT sid="7" pm="."><plain>The cause of <z:e sem="disease" ids="C0920157" disease_type="Disease or Syndrome" abbrv="">mesenteric ischemia</z:e> in one patient could not be determined </plain></SENT>
<SENT sid="8" pm="."><plain>Predictors of mortality collected at T(0) were the following: <z:hpo ids='HP_0000123'>nephritis</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e>, <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS), higher modified SLEDAI-2k, higher damage index score, intravenous <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> use, higher daily dose of <z:chebi fb="0" ids="8382">prednisone</z:chebi>, and higher systolic blood pressure </plain></SENT>
<SENT sid="9" pm="."><plain>Independent predictors of mortality were higher damage index score (HR: 1.40; 95 % CI: 1.08-1.82), <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> use (HR: 3.80; 95 % CI: 1.13-12.77), and APS diagnosis (HR: 3.82; 95 % CI: 1.07-13.59) </plain></SENT>
<SENT sid="10" pm="."><plain>This paper presents a high frequency of late mortality in <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> patients due to the SLE itself and <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>This result is not in agreement with the initial proposed bimodal pattern of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> mortality, nor is it in agreement with the high frequency of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> as a cause of <z:hpo ids='HP_0011420'>death</z:hpo> in developed countries </plain></SENT>
<SENT sid="12" pm="."><plain>The most important predictors of <z:hpo ids='HP_0011420'>death</z:hpo> were related to the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> itself </plain></SENT>
</text></document>